# Vaccination of Children Following Allogeneic Stem Cell Transplantation

> **NCT00169728** · PHASE3 · COMPLETED · sponsor: **Heinrich-Heine University, Duesseldorf** · enrollment: 53 (actual)

## Conditions studied

- Allogeneic Haematopoietic Stem Cell Transplantation

## Interventions

- **BIOLOGICAL:** DTaP-IPV-HBV/Hib combination vaccine, Infanrix hexa
- **BIOLOGICAL:** heptavalent pneumococcal conjugate vaccine, Prevenar

## Key facts

- **NCT ID:** NCT00169728
- **Lead sponsor:** Heinrich-Heine University, Duesseldorf
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-09
- **Primary completion:** 2006-06
- **Final completion:** 2006-10
- **Target enrollment:** 53 (ACTUAL)
- **Last updated:** 2012-06-07

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00169728

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00169728, "Vaccination of Children Following Allogeneic Stem Cell Transplantation". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00169728. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*